CNTB
Connect Biopharma Holdings Ltd
0.9447$
+4.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -139.7% | -34.4% | -1,067.0% | -2,231.7% | – | -26,231.3% | -108,787.5% | -70,312.5% | -9,470.4% | -1,087.1% | -2,440.7% | |
| – | – | 4.0% | 1.4% | 14.4% | 26.4% | – | 356.3% | 1,118.8% | 1,131.3% | 97.0% | 4.9% | 21.3% | |
| – | – | 25.7% | 13.7% | 165.9% | 700.4% | – | 1,981.3% | 5,725.0% | 5,731.3% | 709.5% | 52.5% | 145.8% | |
| – | – | 92.9% | -74.5% | -191.6% | 349.7% | – | -1,095.8% | -7,075.0% | 17,656.3% | 1,205.3% | -1.9% | 117.0% | |
| – | – | 0.1% | 1.8% | 12.1% | 44.7% | – | 631.3% | 212.5% | 100.0% | 0.0% | 0.5% | 2.1% | |
| – | – | 339.2% | 51.7% | – | -2,252.0% | – | 10,685.4% | – | 68,650.0% | – | 52.1% | – | |
| – | – | -1.0% | 0.5% | 0.0% | 39.0% | – | 335.4% | 1,343.8% | 4,468.8% | 10,427.2% | 645.2% | 1,195.1% | |
| – | – | -676.8% | 120.2% | -1,037.5% | -4,576.2% | – | -14,743.8% | -17,418.8% | 3,125.0% | 4,549.7% | -385.8% | -188.9% | |
| – | – | -139.8% | -34.9% | -1,079.1% | -2,276.4% | – | -26,862.5% | -109,000.0% | -70,412.5% | -9,470.4% | -703.5% | -2,083.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.